131st MAINE LEGISLATURE
		LD 132		LR 143(04)
	An Act to Require Health Insurance Carriers to Provide Coverage for Blood Testing for Perfluoroalkyl and Polyfluoroalkyl Substances
	Fiscal Note for Senate Amendment " " to Committee Amendment "A"
	Sponsor: Sen. Rotundo of Androscoggin
	Fiscal Note Required: Yes
Fiscal Note
			FY 2023-24	FY 2024-25	Projections  FY 2025-26	Projections  FY 2026-27
Net Cost (Savings)
	General Fund		$0	($90,000)	($180,000)	($180,000)
	Highway Fund		$0	$0	$0	$0
Appropriations/Allocations
	General Fund		$0	($90,000)	($180,000)	($180,000)
	Highway Fund		$0	$0	$0	$0
Fiscal Detail and Notes
	This amendment adds language stating the Legislature's finding that the requirements for coverage of blood testing for PFAS are not an addition to the State's essential health benefits that would require the State to defray costs pursuant to the federal Patient Protection and Affordable Care Act. Assuming this is a valid argument, the General Fund appropriations to the Department of Administrative and Financial Services of $90,000 for the estimated cost to reimburse insurance carriers for 6 months of the State's defrayal cost of this new mandate are removed. If this argument is deemed invalid in the future, there could potentially be up to $180,000 annual unfunded costs in the program in future biennia.